PERSPECTA

News from every angle

← Back to headlines

Carlsmed targets $70M–$75M 2026 revenue with cervical and bilateral product launches amid 44% growth outlook

26 Feb, 00:48 — 26 Feb, 00:48
PostShare
Only 1 source covers this story